The unexpected COVID-19 outbreaks in China demonstrate a lack of effectiveness of its vaccines,” raising worldwide worries, particularly in countries where Beijing’s vaccines have been adopted, according to Tibet Press.
According to the news source, the Turkish government, which first approved Chinese vaccinations, is now scrutinising their efficacy after learning of China’s role in data tempering of adverse effects just to increase vaccine sales. In December 2020, Indonesia and Brazil initially claimed 97% and 78% effectiveness in Chinese vaccinations, respectively. In 2021, Indonesia and Brazil lowered their efficacy to 65.4% and 50.4%, respectively.
Both countries expressed alarm about the serious adverse effects of the COVID vaccination. According to Tibet Press, with the return of COVID-19 cases and deaths, Thailand and Singapore discontinued the use of Chinese vaccinations and began utilising vaccines manufactured by AstraZeneca and Pfizer.
By 2021, China had provided 2.4 billion doses to its population, and about 1.3 billion vaccine doses had been disseminated globally. Sinopharm claimed to have supplied more than 3.5 billion doses worldwide by 2022.
According to the news article, the majority of Chinese vaccine imports came from Indonesia, Brazil, Pakistan, Turkey, Iran, the Philippines, Morocco, Thailand, Argentina, Venezuela, Cambodia, Sri Lanka, Chile, Mexico, and Bangladesh.
According to “Statistical Table of Adverse Reactions to COVID-19 Vaccines”(2022) published by Laishui County’s community health centre in Baoding City of Hebei Province, people injected with Chinese vaccines have suffered adverse reactions including fever, nausea, diarrhoea, and more deaths, according to Tibet Press report.
A document issued by the Baoding Municipal Leadership Team for Epidemic Response that leaked online claimed that Chinese authorities quarantined a person for 47 days despite being fully vaccinated with vaccines made in China.
Documents that were leaked were labelled as “extra urgent and non-disclosure to the public” and they called for an increase in the monitoring of people with adverse reactions which resulted in China launching a “zero-COVID policy,” as per the news report.
The Baoding Municipal Government’s Foreign Affairs Office issued policies saying that “those tested IgM positive must be quarantined at a centralised site” and released only after testing negative.
As IgM emerges in the early stages of COVID-19, Chinese authorities undertake fast tests. However, IgM antibodies being positive after being vaccinated and detained for almost 47 days is exceptional.
According to Tibet Press, this is how China executed its zero-COVID policy when their vaccinations failed to deliver on their promises.
Notably, China’s zero-COVID policy included harsh measures like as lockdowns, mass testing, and travel bans. China began addressing this issue by developing the world’s first “inhalable COVID vaccination” for the elderly.
According to a poll, more than 60% of persons in the Chinese region of Sichuan tested positive for Covid-19, according to NHK World.
